Articles with public access mandates - Anna WaldLearn more
Not available anywhere: 12
Oral mucosal reactivation rates of herpesviruses among HIV‐1 seropositive persons
E Griffin, E Krantz, S Selke, ML Huang, A Wald
Journal of medical virology 80 (7), 1153-1159, 2008
Mandates: US National Institutes of Health
Nonprimary maternal cytomegalovirus infection after viral shedding in infants
I Boucoiran, BT Mayer, EM Krantz, A Marchant, S Pati, S Boppana, A Wald, ...
The Pediatric infectious disease journal 37 (7), 627-631, 2018
Mandates: US National Institutes of Health
Performance of commercial enzyme-linked immunoassays for diagnosis of herpes simplex virus-1 and herpes simplex virus-2 infection in a clinical setting
E Agyemang, QA Le, T Warren, AS Magaret, S Selke, C Johnston, ...
Sexually Transmitted Diseases 44 (12), 763-767, 2017
Mandates: US National Institutes of Health
Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status
NR Mugo, L Eckert, AS Magaret, A Cheng, L Mwaniki, K Ngure, C Celum, ...
Vaccine 36 (46), 7025-7032, 2018
Mandates: US National Institutes of Health
Time trends in first-episode genital herpes simplex virus infections in an urban sexually transmitted disease clinic
N Dabestani, DA Katz, J Dombrowski, A Magaret, A Wald, C Johnston
Sexually Transmitted Diseases 46 (12), 795-800, 2019
Mandates: US National Institutes of Health
One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection
JB Bavaro, L Drolette, DM Koelle, J Almekinder, T Warren, S Tyring, ...
Sexually transmitted diseases 35 (4), 383-386, 2008
Mandates: US National Institutes of Health
Clinical burden of herpes simplex virus disease in people with human immunodeficiency virus
TM Keating, AE Kurth, A Wald, EM Kahle, EA Barash, SE Buskin
Sexually transmitted diseases 39 (5), 372-376, 2012
Mandates: US National Institutes of Health
Knowledge is power: a case for wider herpes simplex virus serologic testing
A Wald
JAMA pediatrics 167 (8), 689-690, 2013
Mandates: US National Institutes of Health
Antibody responses to prophylactic quadrivalent human papillomavirus vaccine at 48 months among HIV-infected girls and boys ages 9–14 in Kenya, Africa
N Mugo, LO Eckert, L Odero, S Gakuo, K Ngure, C Celum, JM Baeten, ...
Vaccine 39 (33), 4751-4758, 2021
Mandates: US National Institutes of Health
Awareness and correlates of HIV pre-exposure prophylaxis (PrEP) among HIV-negative people who access syringe services in Seattle, Washington
MA Corcorran, JD Scott, J Tinsley, A Wald, SN Glick
Substance Use & Misuse 57 (3), 337-343, 2022
Mandates: US National Institutes of Health
The Coronavirus Disease 2019 Pandemic Unmasked the Challenges Faced by Early-Stage Faculty in Infectious Diseases: A Call to Action
EM Scherer, M Backer, K Carvajal, L Danziger-Isakov, S Frey, LM Howard, ...
Clinical Infectious Diseases 76 (4), 753-759, 2023
Mandates: US National Institutes of Health
009.4 Estimating hsv-2 superinfection using a novel custom genotyping platform
C Johnston, A Magaret, C Sather, K Diem, M Huang, S Selke, ...
Sexually Transmitted Infections 91 (Suppl 2), A46-A46, 2015
Mandates: US National Institutes of Health
Available somewhere: 259
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2
C Celum, A Wald, JR Lingappa, AS Magaret, RS Wang, N Mugo, ...
New England journal of medicine 362 (5), 427-439, 2010
Mandates: US National Institutes of Health
Efficacy results of a trial of a herpes simplex vaccine
RB Belshe, PA Leone, DI Bernstein, A Wald, MJ Levin, JT Stapleton, ...
New England Journal of Medicine 366 (1), 34-43, 2012
Mandates: US National Institutes of Health
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial
C Celum, A Wald, J Hughes, J Sanchez, S Reid, S Delany-Moretlwe, ...
The Lancet 371 (9630), 2109-2119, 2008
Mandates: US National Institutes of Health
Maternal and neonatal herpes simplex virus infections
L Corey, A Wald
New England Journal of Medicine 361 (14), 1376-1385, 2009
Mandates: US National Institutes of Health
Persistence of HIV-1 receptor–positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition
J Zhu, F Hladik, A Woodward, A Klock, T Peng, C Johnston, M Remington, ...
Nature medicine 15 (8), 886-892, 2009
Mandates: US National Institutes of Health
Determinants of per-coital-act HIV-1 infectivity among African HIV-1–serodiscordant couples
JP Hughes, JM Baeten, JR Lingappa, AS Magaret, A Wald, G de Bruyn, ...
Journal of Infectious Diseases 205 (3), 358-365, 2012
Mandates: US National Institutes of Health
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission
JM Baeten, E Kahle, JR Lingappa, RW Coombs, S Delany-Moretlwe, ...
Science translational medicine 3 (77), 77ra29-77ra29, 2011
Mandates: US National Institutes of Health
Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women
DI Bernstein, AR Bellamy, EW Hook III, MJ Levin, A Wald, MG Ewell, ...
Clinical infectious diseases 56 (3), 344-351, 2013
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program